| Entry |
|
|---|
| Name |
Altretamine (USP/INN);
Hexalen (TN) |
|---|
| Formula |
C9H18N6
|
|---|
| Exact mass |
210.1593
|
|---|
| Mol weight |
210.28
|
|---|
| Structure |
|
|---|
| Remark |
|
|---|
| Efficacy |
Antineoplastic, Alkylating agent |
|---|
| Disease |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01X OTHER ANTINEOPLASTIC AGENTS
L01XX Other antineoplastic agents
L01XX03 Altretamine
D02841 Altretamine (USP/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 15
1 C8y C 23.5900 -15.4000
2 N5x N 23.5900 -16.8000
3 C8y C 24.7800 -17.5000
4 N5x N 26.0400 -16.8000
5 C8y C 26.0400 -15.4000
6 N5x N 24.7800 -14.7000
7 N1c N 27.2300 -14.7000
8 C1a C 27.2300 -13.3000
9 C1a C 28.4200 -15.4000
10 N1c N 24.7800 -18.9000
11 C1a C 26.0400 -19.6000
12 C1a C 23.5900 -19.6000
13 N1c N 22.4000 -14.7000
14 C1a C 21.1400 -15.4000
15 C1a C 22.4000 -13.3000
BOND 15
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 5 7 1
8 7 8 1
9 7 9 1
10 3 10 1
11 10 11 1
12 10 12 1
13 1 13 1
14 13 14 1
15 13 15 1
|
|---|
